This content is machine translated Treating reflux symptoms Doing one thing but not the other Proton pump inhibitors (PPI) are still the first choice for acute treatment, but long-term use should be avoided. H2 antihistamines also suppress gastric acid secretion. Antacids and alginates can also…
View Post 5 min This content is machine translated Gastroesophageal reflux disease (GERD) Alginate as an as-needed add-on therapy increases patient satisfaction The standard therapy for treating all manifestations of reflux disease is proton pump inhibitors (PPI). Despite a high success rate, there are occasional patients with an insufficient response to therapy.…
View Post 2 min This content is machine translated Reflux Cases The consequences of prophylactic PPI therapy A 28-year-old patient presents with persistent reflux symptoms that first appear after discontinuation of PPI therapy.
View Post 4 min This content is machine translated Swiss Family Docs - Infectiology Use antibiotics in a targeted and restrained manner At the Swiss Family Docs Congress, Prof. Rainer Weber, MD, Director of the Clinic for Infectious Diseases and Hospital Hygiene, Zurich, provided information on infectious disease topics in a well-attended…
View Post 3 min This content is machine translated Reflux/stomach burn Treat the reflux – not the acidosis With classical therapy of acid inhibition, residual symptoms of gastroesophageal reflux disease sometimes persist. Renowned speakers from medicine and pharmacy discussed the topic at a round table in Zurich. A…
View Post 7 min This content is machine translated Rheumatology, Geriatrics, Gastroenterology & Pneumology What’s new in internal medicine? At this year’s SGIM annual meeting, the update presentations were again very popular. And rightly so, because once again the audience learned a lot of interesting facts about the latest…
View Post 6 min This content is machine translated Roundtable discussion Use of conventional NSAIDs and coxibs in high-risk patients. Conventional NSAIDs and coxibs differ in their risk profile and tolerability, which is particularly important to consider in high-risk patients. But how to proceed? HAUSARZT PRAXIS in conversation with four…
